Header Logo

Connection

JOSEPH JANKOVIC to Tics

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Tics.
JOSEPH JANKOVIC
Connection Strength
11.107
Tics
  1. Axial tics in Tourette syndrome and chronic tic disorders. J Neurol. 2024 Nov; 271(11):7232-7238.
    View in: PubMed
    Score: 0.878
  2. Tics emergencies and malignant tourette syndrome: Assessment and management. Neurosci Biobehav Rev. 2024 Apr; 159:105609.
    View in: PubMed
    Score: 0.844
  3. Real-world experience with VMAT2 inhibitors in Tourette syndrome. J Neurol. 2023 Sep; 270(9):4518-4522.
    View in: PubMed
    Score: 0.803
  4. Contrasting features between Tourette syndrome and secondary tic disorders. J Neural Transm (Vienna). 2023 07; 130(7):931-936.
    View in: PubMed
    Score: 0.796
  5. Oromandibular tics associated with Tourette syndrome. J Neurol. 2023 May; 270(5):2591-2596.
    View in: PubMed
    Score: 0.783
  6. Dystonic motor and phonic tics in Tourette syndrome. J Neurol. 2022 Oct; 269(10):5312-5318.
    View in: PubMed
    Score: 0.745
  7. The clinical phenomenology and correlations of oculogyric tics. Acta Neurol Belg. 2022 Aug; 122(4):925-930.
    View in: PubMed
    Score: 0.740
  8. Self-injurious behavior in Tourette syndrome. J Neurol. 2022 May; 269(5):2453-2459.
    View in: PubMed
    Score: 0.714
  9. Beyond tics: movement disorders in patients with Tourette syndrome. J Neural Transm (Vienna). 2021 08; 128(8):1177-1183.
    View in: PubMed
    Score: 0.704
  10. Real-World Experience With VMAT2 Inhibitors. Clin Neuropharmacol. 2019 Mar/Apr; 42(2):37-41.
    View in: PubMed
    Score: 0.597
  11. Botulinum Toxin for the Treatment of Tremor and Tics. Semin Neurol. 2016 Feb; 36(1):54-63.
    View in: PubMed
    Score: 0.483
  12. Therapeutic Developments for Tics and Myoclonus. Mov Disord. 2015 Sep 15; 30(11):1566-73.
    View in: PubMed
    Score: 0.468
  13. Motor-phonic tic mimicking essential palatal myoclonus. Mov Disord. 2009 Oct 15; 24(13):2030-2.
    View in: PubMed
    Score: 0.311
  14. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology. 2007 Jan 09; 68(2):159-60.
    View in: PubMed
    Score: 0.257
  15. Tics associated with other disorders. Adv Neurol. 2006; 99:61-8.
    View in: PubMed
    Score: 0.240
  16. Secondary tics and tourettism. Braz J Psychiatry. 2005 Mar; 27(1):11-7.
    View in: PubMed
    Score: 0.228
  17. Differential diagnosis and etiology of tics. Adv Neurol. 2001; 85:15-29.
    View in: PubMed
    Score: 0.169
  18. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics. 2020 10; 17(4):1681-1693.
    View in: PubMed
    Score: 0.166
  19. Botulinum toxin in the treatment of tics. Arch Neurol. 2000 Aug; 57(8):1190-3.
    View in: PubMed
    Score: 0.165
  20. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 05 07; 92(19):896-906.
    View in: PubMed
    Score: 0.151
  21. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 05 07; 92(19):907-915.
    View in: PubMed
    Score: 0.151
  22. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470.
    View in: PubMed
    Score: 0.128
  23. Deep brain stimulation for Tourette syndrome: target selection. Stereotact Funct Neurosurg. 2012; 90(4):213-24.
    View in: PubMed
    Score: 0.094
  24. Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord. 2010 Oct 30; 25(14):2470-2.
    View in: PubMed
    Score: 0.084
  25. Tourette's syndrome in adults. Mov Disord. 2010 Oct 15; 25(13):2171-5.
    View in: PubMed
    Score: 0.083
  26. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec; 16(10):628-38.
    View in: PubMed
    Score: 0.082
  27. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007 Jan 15; 22(2):193-7.
    View in: PubMed
    Score: 0.064
  28. Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy. Mov Disord. 2006 Aug; 21(8):1273-5.
    View in: PubMed
    Score: 0.062
  29. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 10 01; 4(10):e2129397.
    View in: PubMed
    Score: 0.045
  30. Bilineal transmission in Tourette syndrome. Neurology. 1999 Sep 11; 53(4):813-8.
    View in: PubMed
    Score: 0.039
  31. Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009 Mar; 51(3):218-27.
    View in: PubMed
    Score: 0.018
  32. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx. 2006 Apr; 3(2):192-206.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.